Global Nutrigenomics Market - Forecast And Strategic Analysis, 2026-2032 AI And Multi-Omics Accelerate Precision Nutrition, Driving 17.83% CAGR Toward USD 2.11 Billion


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Boost ROI with validated gene-diet evidence, AI-powered multi-omics platforms, privacy-by-design, and strategic clinical and research partnerships.

Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Nutrigenomics Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The global nutrigenomics market research report examines the transition of precision nutrition from a niche wellness concept into a data-driven industry connecting genetic variation with dietary response, metabolic risk, and personalized health guidance. The market is projected to reach USD 785.88 million in 2026 and grow at a CAGR of 17.83% to USD 2.11 billion by 2032.

Growth is supported by declining DNA sequencing costs, advances in genomic research, increasing demand for personalized nutrition, and the global burden of diet-related noncommunicable diseases. The analysis gives decision-makers a practical foundation for evaluating market opportunities, competitive positioning, and responsible commercialization strategies.

Transformative Market Shifts

Affordable genotyping, multi-omics analytics, wearable health data, and preventive care trends are reshaping nutrigenomics. Providers are moving beyond single-gene diet claims toward integrated models combining:

  • Genetic variants and blood biomarkers
  • Microbiome profiles and dietary intake
  • Lifestyle behaviors and clinical history
  • Continuous monitoring and digital health records

Regulation and consumer trust are becoming critical differentiators. Privacy requirements, genetic nondiscrimination protections, and scrutiny of direct-to-consumer testing are encouraging stronger consent practices, cybersecurity, clinical validation, and claims substantiation. These factors are also accelerating collaboration among laboratories, nutrition brands, healthcare providers, insurers, and digital therapeutics platforms.

Artificial Intelligence and Advanced Analytics

Artificial intelligence expands the ability to identify patterns across genomic variants, biomarkers, microbiome data, dietary records, continuous glucose monitoring, and lifestyle information. AI-enabled systems can support scalable personalization, adaptive nutrition coaching, and research into gene-nutrient interactions.

However, biased training data, limited genomic diversity, and insufficient clinical validation can undermine recommendations. Explainable models, inclusive datasets, expert oversight, secure governance, and ongoing evidence generation are therefore essential. These insights support risk mitigation by highlighting the technical and ethical safeguards required for credible deployment.

Regional Market Dynamics

  • North America: Leads through advanced genetic testing infrastructure, digital health adoption, preventive wellness demand, and familiarity with DNA-based insights.
  • Europe: Emphasizes privacy governance, clinical research standards, public health nutrition, and evidence-based claims.
  • Asia-Pacific: Expands through rising wellness spending, growing genomics capacity, aging populations, and chronic disease prevention.
  • Latin America: Presents opportunities for affordable, culturally relevant interventions addressing obesity, diabetes, and cardiovascular risk.
  • Middle East: Benefits from genomics investment, premium wellness services, and national programs targeting metabolic disease.
  • Africa: Offers long-term potential through genomic diversity, mobile health adoption, nutrition initiatives, and precision public health research.

Strategic Group and Country Signals

ASEAN markets benefit from urbanization and mobile-first healthcare, while GCC countries are building precision health capabilities through national genomics programs. The European Union remains a benchmark for responsible adoption, and BRICS markets offer scale, genomic diversity, and localized nutrition needs. G7 economies support premium innovation through mature diagnostics, biotechnology investment, and digital health ecosystems.

The United States remains a major market, while Canada, Mexico, and Brazil offer distinct opportunities shaped by privacy expectations and chronic disease prevention. China and India provide scale and diverse dietary profiles; Japan and South Korea contribute advanced aging and wellness markets; and Australia combines biotechnology capabilities with strong preventive health awareness. This geographic assessment can inform market-entry priorities and localized product strategies.

Strategic Priorities for Industry Leaders

  • Invest in validated gene-diet evidence and transparent reporting.
  • Align claims with regulatory requirements and scientific limitations.
  • Integrate genetics with biomarkers, microbiome insights, and lifestyle data.
  • Develop culturally relevant and practical dietary guidance.
  • Partner with accredited laboratories, dietitians, healthcare providers, and researchers.
  • Embed privacy, explainable AI, consent management, cybersecurity, and outcome tracking into platform design.

Key Takeaways from This Report

  • The market is forecast to reach USD 2.11 billion by 2032 at a 17.83% CAGR.
  • Integrated multi-omics models are replacing isolated gene-based recommendations.
  • Scientific validation, data privacy, inclusivity, and trust will define competitive advantage.
  • Regional success depends on affordability, regulation, clinical readiness, and cultural relevance.
  • Responsible AI and strategic partnerships are central to scalable commercialization.

Key Attributes:

Report Attribute Details
No. of Pages 196
Forecast Period 2026 - 2032
Estimated Market Value (USD) in 2026 $785.88 Million
Forecasted Market Value (USD) by 2032 $2110 Million
Compound Annual Growth Rate 17.8%
Regions Covered Global


Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026

7. Nutrigenomics Market, by Offering
7.1. Introduction
7.2. Reagents & Kits
7.3. Services
7.3.1. Genetic Counseling Services
7.3.2. Research & Development Services
8. Nutrigenomics Market, by Technique
8.1. Introduction
8.2. Blood
8.3. Buccal Swab
8.4. Saliva
9. Nutrigenomics Market, by Technology
9.1. Introduction
9.2. Bioinformatics & Data Analytics
9.3. Genotyping
9.4. Microarray Technology
9.5. Next Generation Sequencing (NGS)
9.6. Polymerase Chain Reaction (PCR)
10. Nutrigenomics Market, by Application
10.1. Introduction
10.2. Cancer Prevention & Management
10.3. Disease Management
10.3.1. Cardiovascular
10.3.1.1. Cholesterol
10.3.1.2. Hypertension
10.3.2. Diabetes
10.3.2.1. Type 1
10.3.2.2. Type 2
10.3.3. Obesity
10.4. Personalized Nutrition
10.5. Sports Nutrition
10.5.1. Endurance
10.5.2. Post Workout
10.5.3. Pre Workout
10.6. Weight Management
11. Nutrigenomics Market, by End-User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Fitness & Wellness Centers
11.4. Hospitals & Clinics
11.5. Research & Academic Institutes
12. Nutrigenomics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Nutrigenomics Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Nutrigenomics Market, by Country
14.1. Introduction
14.2. United States
14.3. Germany
14.4. China
14.5. India
14.6. United Kingdom
14.7. Japan
14.8. Canada
14.9. Russia
14.10. Brazil
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Atlas Laboratories Ltd.
16.2. DNAlife
16.3. EliteVita
16.4. Genomics Research and Solutions Pvt Ltd.
16.5. Genosalut Balear SL
16.6. Genova Diagnostics Inc.
16.7. GX Sciences, LLC
16.8. HOLISTIC HEALTH INTERNATIONAL, LLC
16.9. LifecodeGx Ltd
16.10. Mapmygenome
16.11. myDNA Life Australia Pty Ltd.
16.12. NuGenomics
16.13. Nutrigenomix Inc.
16.14. Randox Health LTD
16.15. The Gene Box
16.16. Wellness Psychiatry, PLLC
16.17. Xcode Life
17. Key Experts

List of Figures [21]
List of Tables [388]
For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN19112026004107003653ID1111990331


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search